News Focus
News Focus
Followers 1
Posts 307
Boards Moderated 0
Alias Born 07/24/2015

Re: BaaBaa45 post# 148360

Monday, 10/08/2018 12:45:47 PM

Monday, October 08, 2018 12:45:47 PM

Post# of 447425
Baabaa,

Amarin has a monopoly on Vascepa until the end of exclusivity/patents. What you suggested was locking up API sources by buying them. A monopoly on EPA is not the same as a monopoly on V.

Could Amarin lock up much of the API in long-term contracts, putting up high barriers for competitors? Absolutely. However if they went too far with this strategy it could potentially lead to antitrust action. I also agree that they could vertically integrate, but doubt its worth the hassle.

In any case, trying to monopolize something so ubiquitous seems futile
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News